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Anyone who has had experience with bismuth therapy in
syphilis knows how frequently a bluish pigmentation on the gums
is encountered in these patients. In most instances this pig-
mentation is harmless and is no indication for suspending therapy.
Where oral sepsis is present, due either to lack of oral hygiene or
to individual peculiarities, the incidence and extent of pigmenta-.
tion is much greater and may be a forerunner of a more severe,
ulcerative, necrotic or gangrenous process of the mucous mem-
brane of the mouth. Fortunately, the occurrence of the severe
reactions to bismuth is quite infrequent as compared with the
high incidence of bluish pigmentation of the gums only. F. P.
McCarthy and Smith 0. Dexter, Jr. (1) found pigmentation and
gingivitis in 80 per cent of the patients. S. Irgang, E. R. Alex-
ander, and A. M. Sala (2) found a blue line in the gums of nearly
100 per cent of their patients. M. A. Galliot (3) reported 73
patients with a light stomatitis in 1,000 injections of a fat soluble
bismuth. In our clinic 100 patients out of the 150 under treat-
ment during the years 1938 and 1939 showed some manifestations
in the oral cavity that were attributable to bismuth. These 150
patients were given repeated courses of treatment. Each course
consisted of 10 weekly intramuscular injections of 0.2 gram of
bismuth subsalicylate in 2 cc. of peanut oil.
The following table gives the type and number of reactions
f&und in the 100 patients having a bismuth line.
* From the Departments of Dermatology and Physiology, Northwestern
University Medical School, Chicago, Illinois.
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TYPE OF REACTION NUMBER OF
Bismuth blue line 73
Bismuth blue line—gingivitis 11
Bismuth blue line—mild stomatitis 5
Bismuth blue line—severe ulceration of alveolar, gingival, lingual,
buccal mucosa 3
Tenderness of gums without pigmentation 8
Close observation of our syphilitic patients led us to the same
conclusions which other writers, such as Hesse (4) and Lebourg
(5) had reached previously—that uncleanliness of the mouth,
tartar on the enamel, carious teeth and roots, and foci of infection
in the oral cavity were the most important factors in the deposit
of bismuth pigmentation or in the production of more serious
lesions of the mucous membrane. We were confronted then with
the problem of eliminating these factors as far as it was practical.
The first step, naturally, was prompt and adequate dental in-
spection and treatment when it was indicated. This however,
was not sufficient to prevent bismuth pigmentation, even though
frequently repeated. An effective agent was required which
would exert a local detergent action and would reduce the chemical
affinity of the bismuth for the mucous membranes of the gums,
but which would not be harmful to the tissues.
Sodium hexametaphosphate is a water soluble complex salt of
metaphosphoric acid of the composition (NaPO3)e. It is formed
by the loss of one molecule of water from the ordinary sodium
dihydrogen phosphate, NaH2PO4. According to Smith (6), when
soluble calcium or magnesium salts are added to a solution of
sodium hexametaphosphate, instead of precipitates of phosphates
being formed as would be the case with the ortho-phosphate, a
soluble compound is formed as shown by the following reaction:
2CaC12 + (NaPO3)6 — Na(Ca2P6O) + 4NaCl
In this compound the calcium is part of the anion and loses its
basic properties completely.
Bismuth can combine with sodium hexametaphosphate in
much the same way as calcium does to form the compound,
Na(BiP6O18).
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In the mouth, calcium from the food, the drinking water, and
tissue secretions forms insoluble plaques with protein, carbonic
acid, and phosphoiic acid. Under these plaques, bacteria are
able to dissolve the enamel of the teeth. Under such conditions,
bismuth, when present in the blood stream, can be precipitated
in the teeth and gums. The prevention of calcareous deposits
in the mouth prevents, to a large extent, the precipitation of
bismuth and the lesions which this precipitation produces.
Since sodium hexametaphosphate in solution tends to revert
to the ineffective orthophosphate, the compound was used as a
fine powder mixed with talc in the proportion of 15 parts of
metaphosphate to 85 parts of talc. This gave a convenient
preparation which could be used effectively on a brush and one
that would remove calcareous deposits, tartar, and food deposits,
from the teeth and gums, and by so doing prevent the formation
of mucous plaques. By tying all free calcium ions into a soluble,
non-ionizable compound, precipitation of bismuth was prevented
and bismuth was removed from the mouth.
Unlike strong oxidizing agents, such as potassium chlorate and
perborate, the sodium hexametaphosphate does not injure the
gum tissue. It has a mild bacteriostatic effect and a definite
protective effect on epithelial tissue as shown by Jones, Murray,
and Ivy (7).
In the use of this preparation, each patient in the syphilis
clinic who received this powder was instructed to use it as a tooth
powder on a brush after each meal and at bed time. It was
given only to patients who had a history of having had a bismuth
reaction in the oral cavity before, or who showed some bismuth
manifestation during the current course of treatment—from the
slightest pigmentation to the ulcerative lesions—and those who
showed foci of infection about the gums and teeth before any
pigmentation was present.
In general, the use of this powder by the entire group of 100
patients, reduced noticeably the incidence and severity of bis-
muth reactions in the oral cavity. More specifically, the large
group of treated patients was divided into smaller groups for
study, each group consisting of patients who had somewhat
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similar experiences. These groups were designated A, B, C,
and D.
GROUP A
In the first group were included 8 patients whose bismuth
therapy was suspended because of rapidly progressive lesions of
the buccal cavity. All these patients commenced the use of the
powder either after bismuth was stopped or after the dosage was
reduced. Of this small group 2 patients with a rapidly increasing
bismuth line and gingivitis were able to resume bismuth therapy
in 2 weeks, and 2 more patients with similar lesions, in 4 weeks,
after the powder was used. These patients not only finished
their interrupted course, but also received later 2 more full
courses of bismuth without any interruption. They used the
powder regularly during the periods of anti-syphilitic treatment—
arsenic or bismuth—as well as during the rest periods. After
their last course of bismuth injections only a mild pigmentation
was present on the gums.
Two more patients in this sub-group were compelled to stop
bismuth because of a severe grade of pyorrhea alveolaris, carious
teeth and roots, and a progressive bismuth pigmentation on the
gums. They began to use our powder immediately after stopping
the bismuth and while they were receiving dental treatment. In
six weeks they resumed bismuth treatment with only a narrow
line of pigment present on the gums. They finished that course
and two more courses later with no ill effects other than a mild
gingival blue line. They used the powder regularly as the pre-
ceding four patients did.
In another patient of this group, a young woman, 26 years old,
the powder failed to check a rapidly developing bismuth pig-
mentation accompanied by a severe ulcerative stomatitis and
albuminuria even though previously the patient had received 3
courses of bismuth (10 injections each) with no complications.
After the fifth injection of the fourth course a blue bismuth pig-
mentation was noticed on the gums. The patient was given the
powder. Only half of the previous dose of bismuth (0.1 gram)
was injected. After the seventh injection (2 more half-doses)
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the patient became so acutely ill with rapid progression of the
lesions of the oral cavity and albuuiinuria that hospitalization
became urgent. After a nine days' stay in the hospital the pa-
tient improved suffieiently to go home but remained quite weak
for several months. Again, apical abscesses and a severe grade
of carious teeth were responsible for the toxic effects of the bis-
muth on all the tissues. The powder was ineffective in the
presence of extensive foci of infection but was used regularly in
spite of this fact. In 6 months, during which time the patient
received proper dental treatment, general tonics and no anti-
syphilitic therapy, full recovery was made with freedom from
lesions or pigmentation in the mouth and from albumin in the
urine. A course of mapharsen and a course of bismuth in one
half doses has been given since then with no signs of intolerance.
The last patient in this group was a young woman who began
her anti-syphilitic treatment in the third trimester of pregnancy.
After the first injection of bismuth (0.1 gram) a severe stomatitis
and gingivitis followed. Upon examination of the oral cavity
several carious teeth with irritated alveoli were found. A pre-
vious mild decay of the teeth was augmented by the decalcification
process during pregnancy which resulted in an irritation of the
alveoli that in turn provoked a toxic reaction from the bismuth
upon the mucous membrane. The patient was given the powder
to cleanse the mouth and mapharsen was substituted for the bis-
muth. In a few weeks the lesions in the mouth healed, as the
patient continued with the arsenical injections to the end of the
term. In this case the results are inconclusive, as the bismuth
was not resumed and this suspension was perhaps sufficient cause
for recovery. It was interesting to note, however, that the sodium
hexametaphosphate did not intensify the decay of the teeth.
GROUP B
In this group are included four patients who retained an intoler-
ance to bismuth even after they had received proper dental care.
Before they began to use the powder, they had never been able
to finish a course of bismuth because of lesions in the mouth,
heavy pigmentation, or gingivitis and stomatitis. They had
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used a mouth wash consisting of potassium chlorate in alkaline
aromatic solution during their bismuth treatment and after the
injections were stopped. This mouthwash was helpful in clearing
up the lesions while the patients were not on bismuth therapy,
but with the resumption of bismuth the lesions recurred after
several injections even with the use of the mouthwash. Since
these patients began the use of the metaphosphate powder during
their bismuth as well as during their arsenical treatment and
during their rest periods, they were enabled to finish two or three
full courses of bismuth with only mild reactions in the mucous
membrane that did not interfere with the therapy.
GROUP C
Here are grouped eight patients who showed definite indica-
tions for dental treatment before commencing anti-syphilitic
therapy. It had been our practice before to postpone bismuth
therapy in such cases until the oral cavity reached a definite
state of improvement. This often required a delay of many
weeks in the bismuth treatment. These eight patients were
given our powder immediately after the examination and some
were enabled in one week, others in two or three weeks, to begin
the bismuth injections, while they were still under treatment in
the dental department. Inspection of the oral cavity during and
after the bismuth course revealed only faint deposits on the gums.
We instructed these patients, too, to use the powder regularly
during their periods of treatment and rest.
GROUP D
This category includes about four-fifths of the one hundred
patients under observation who used the powder. Some of these
patients showed different degrees of pigmentation of the gums,
others complained of a soreness of the gums, showing no bismuth
deposit at all and still others had in general poor oral hygiene.
In some instances the pigment was in a broad band, deposited
during preceding courses of bismuth therapy; in others the
deposit developed during a current course of treatment. All of
these patients using the powder continued their bismuth and
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arsenical therapy with no interruption, receiving from two to four
courses of each. In some cases the pigmentation became fainter
in the face of continued bismuth treatment; in others the lesions
did not progress. About one half of the patients who complained
of soreness of the gums, or of their mouths, were relieved after
the use of the powder. Certainly there was a definite improve-
ment of the mouth hygiene of all those who showed lesions.
CONCLUSIONS
It is quite clear to the authors that for a scientific evaluation
of the benefits derived from sodium hexametaphosphate and talc
powder in Group D. in particular, and in all the groups in general,
there should have been two more control groups, each consisting
of approximately the same number and type of patients—one
group using plain Venetian talc and the other nothing at all.
The results of all three groups could be compared directly. But
past experience with similar patients, seemed to control ade-
quately the effect of no medication. According to this experience,
those patients with moderately heavy pigmentation and unclean
mouths would have developed progressive lesions in the oral
mucosa if left without any local treatment. Interruptions in the
antiluetic treatment and perhaps other complications would have
followed. Observing the favorable results in some cases in
Groups A., B., and C. one can conclude that the patients in
Group D. were benefited by using the powder. Although the
effect of the sodium hexametaphosphate seems definite, further
study of this preparation is indicated since the number of patients
used was not large. In spite of the preliminary nature of this
report the results of this investigation, in our opinion warrant
publication at this time so that a wider use will confirm these
findings.
SUMMARY
The use of a powder consisting of 15 per cent sodium hexameta-
phosphate and 85 per cent talc as a dentifrice and oral cleanser in
the mouths of 100 patients receiving intramuscular bismuth
therapy for syphilis has definitely reduced or prevented the mci-
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dence of "bismuth line" in the gums. The use of this powder has
permitted immediate bismuth therapy in cases that ordinarily
would require a delay until oral treatment had been effected.
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